Skip to content

Treatment of Adolescent Idiopathic Scoliosis Patients Using the Ellipse MAGEC System

Treatment of Adolescent Idiopathic Scoliosis Patients Using the Ellipse MAGEC System

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01633931
Enrollment
20
Registered
2012-07-06
Start date
2012-03-31
Completion date
2018-10-31
Last updated
2018-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Idiopathic Scoliosis

Brief summary

The purpose of this study is to collect data on the use of the Ellipse MAGEC System to treat patients with adolescent idiopathic scoliosis (AIS) who have failed external brace therapy.

Interventions

None listed

Sponsors

Ellipse Technologies, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Adolescent Idiopathic Scoliosis * Failed external brace therapy defined as either (a) progression of the curve greater than 5 degrees at any time while undergoing external brace therapy, or (b) inability or unwillingness to comply with at least 16 hours per day of external bracing * Skeletally immature (Risser Sign 0, 1, 2, or 3) * In girls, either (a) pre-menarchal, or (b) post-menarchal by no more than 6 months * Age between 10 and 15 * Primary Cobb angle greater than 25 degrees but not yet requiring spine fusion * Candidate for surgical implantation of spinal instrumentation * Patient resides locally with respect to the Investigator's clinic and is willing and able to comply with the requirements of the protocol * Must sign informed consent to permit the use of personal health data

Exclusion criteria

* Patients with a pacemaker, implanted cardiac defibrillator, or any other electronic implant * Patients who require an MRI following implantation * Skeletally mature (Risser Sign 4 or 5; or fused tri-radiate cartilage) * Diagnosis of other musculoskeletal or developmental illness that might be responsible for the spinal curvature * History of previous surgical treatment for AIS

Design outcomes

Primary

MeasureTime frameDescription
Change in major scoliotic curve magnitudeChange from baseline to 36 months postoperativeMeasured in degrees
Number and Types of Adverse EventsOperative through 36 months postoperative

Secondary

MeasureTime frame
Radiographic evaluation coronal balance compared to baselineChange from baseline to 36 months postoperative
Radiographic evaluation sagittal balance compared to baselineChange from baseline to 36 months postoperative
Comparison of Rib Hump prominenceChange from baseline to 36 months postoperative
Quality of life assessment via SRS-30 questionnaireChange from baseline to 36 months postoperative
Percent of patients indicated for surgical spine fusionChange from baseline to 36 months postoperative
Expected vs. Actual Device LengtheningAll postoperative visits where lengthening is conducted

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026